fluorodeoxyglucose f18 has been researched along with Liver Steatosis in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (10.34) | 29.6817 |
2010's | 20 (68.97) | 24.3611 |
2020's | 6 (20.69) | 2.80 |
Authors | Studies |
---|---|
Duvivier, A; Goyers, JF; Namur, G; Radermacher, J | 1 |
Cui, Z; Han, Y; Liu, J; Tian, X | 1 |
Mori, Y; Novruzov, E; Novruzov, F | 1 |
Fujita, A; Iwabuchi, Y; Jinzaki, M; Nakahara, T; Okada, M; Owaki, Y; Sakurai, R; Shiga, T; Shimizu, A; Tonda, K; Yamada, Y | 1 |
Kaya, G; Keramida, G; Peters, AM; Roldao Pereira, L | 1 |
Andrieu, PC; Becher, T; Cohen, P; Crane, A; Eljalby, M; Jiang, CS; Schöder, H; Vaughan, R; Wibmer, AG | 1 |
Hara, AK; Nguyen, BD; Roarke, MC; Yang, M | 1 |
Arguin, G; Beaudoin, JF; Bourzac, JF; Gendron, FP; Lecomte, R; Molle, CM; Paquette, M; Placet, M; Plourde, M; Rousseau, JA | 1 |
Aide, N; Damaj, G; Fruchart, C; Gac, AC; Lasnon, C; Nganoa, C; Salomon, T | 1 |
Aide, N; Lasnon, C; Salomon, T | 1 |
Hausauer, B; Islam, Z; Keshavamurthy, J; Pucar, D | 1 |
Cho, YS; Choi, JY; Hong, SP; Kim, BT; Lee, EJ; Lee, KH; Moon, SH; Noh, TS | 1 |
Bush, J; Dizdarevic, S; Keramida, G; Peters, AM; Potts, J | 1 |
Cai, L; Chen, Y; Huang, Z; Le, Y; Zhang, L | 1 |
Bush, J; Dizdarevic, S; Keramida, G; Peters, AM; Potts, J; Verma, S | 1 |
Cheng, D; Hu, P; Li, Y; Liu, G; Shi, H | 1 |
Dizdarevic, S; Hunter, J; Keramida, G; Peters, AM | 1 |
Cook, GJ; Dunford, A; Keramida, G; Peters, AM; Siddique, M | 1 |
Bergman, J; Borra, R; Hällsten, K; Iozzo, P; Komu, M; Lautamäki, R; Nuutila, P; Parkkola, R; Sijens, PE | 1 |
Quon, A; Zissen, MH | 1 |
Alavi, A; Alkhawaldeh, K; Basu, S; Bural, GG; Burke, A; Cucchiara, A; Houseni, M; Torigian, DA | 1 |
Abele, JT; Fung, CI | 1 |
Fujimoto, T; Fujita, S; Higashi, R; Kamimura, K; Nagamachi, S; Nakajo, M; Ogita, M; Ueno, S; Umemura, Y; Wakamatsu, H | 1 |
Ding, Y; Guo, X; Hirano, K; Kohno, K; Sasaguri, Y; Tanimoto, A; Tsukada, H; Wang, KY; Watanabe, T; Yamada, S | 1 |
de Roos, A; Diamant, M; Heine, RJ; Lamb, HJ; Lammertsma, AA; Lubberink, M; Rijzewijk, LJ; Romijn, JA; Smit, JW; Twisk, JW; van der Meer, RW | 1 |
Abikhzer, G; Alabed, YZ; Assayag, J; Azoulay, L; Rush, C | 1 |
Atug, O; Imeryuz, N; Kurt, R; Ones, T; Ozguven, S; Purnak, T; Turoglu, HT; Yilmaz, Y | 1 |
Casagrande, V; Federici, M; Gentileschi, P; Hribal, ML; Lauro, D; Lauro, R; Marino, A; Marzano, V; Menghini, R; Menini, S; Pugliese, G; Sbraccia, P; Schillaci, O; Urbani, A | 1 |
Bandou, H; Ishiguro, K; Kinoshita, S; Koizumi, H; Kotake, M; Murakami, N; Yamada, T | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Liver Steatosis
Article | Year |
---|---|
The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Fatty Liver; Fibroblasts; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography | 2023 |
3 trial(s) available for fluorodeoxyglucose f18 and Liver Steatosis
Article | Year |
---|---|
Hepatic steatosis is associated with increased hepatic FDG uptake.
Topics: Computer Simulation; Fatty Liver; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2014 |
Accumulation of (18)F-FDG in the liver in hepatic steatosis.
Topics: Computer Simulation; Fatty Liver; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Liver; Models, Biological; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Up-Regulation | 2014 |
Associations between liver (18)F fluoro-2-deoxy-D-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Biological Transport; Blood Glucose; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Metabolic Syndrome; Middle Aged; Positron-Emission Tomography; Regression Analysis | 2010 |
25 other study(ies) available for fluorodeoxyglucose f18 and Liver Steatosis
Article | Year |
---|---|
[Hypermetabolic multifocal steatohepatitis: a rare case of [18F]FDG PET/CT false positive mimicking a metastatic carcinomatosis].
Topics: Aged; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Detection of liver metastasis by 18F-FAPI PET/CT in the background of fatty liver.
Topics: Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Quinolines | 2023 |
Impact of patient characteristic factors on the dynamics of liver glucose metabolism: Evaluation of multiparametric imaging with dynamic whole-body
Topics: Blood Glucose; Diabetes Mellitus; Fatty Liver; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2023 |
Hepatic and splenic
Topics: Blood Glucose; Diabetes Mellitus; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Metabolic Clearance Rate; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Spleen; Tomography, X-Ray Computed | 2020 |
Brown adipose tissue is associated with healthier body fat distribution and metabolic benefits independent of regional adiposity.
Topics: Adipose Tissue, Brown; Adiposity; Body Fat Distribution; Cohort Studies; Diabetes Mellitus, Type 2; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Metabolome; Middle Aged; Multivariate Analysis; Positron Emission Tomography Computed Tomography | 2021 |
Concurrent focal fat sparing and peritumoral fat sparing in diffuse fatty liver identified on 18F-FDG PETCT and multiparametric magnetic resonance imaging.
Topics: Aged; Colorectal Neoplasms; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography | 2017 |
The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.
Topics: Absorption, Physiological; Animals; Biological Transport; Cholesterol; Down-Regulation; Dyslipidemias; Enterocytes; Fatty Liver; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 2; Hyperglycemia; Insulin; Insulin Resistance; Intestines; Jejunum; Lipid Metabolism; Male; Mice; Receptors, Purinergic P2X7; Tissue Distribution; Triglycerides; Weight Gain | 2017 |
Assessment of alteration in liver
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoma; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2018 |
Reply to the Letter to the Editor from Peters et al: On the use of the liver as a reference organ for Deauville scoring in lymphoma patients and how it may be affected by liver steatosis.
Topics: Biological Transport; Fatty Liver; Fluorodeoxyglucose F18; Humans; Lymphoma | 2018 |
Rapidly Lethal Ruptured Hepatocellular Carcinoma With Disseminated Peritoneal Carcinomatosis on FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography | 2019 |
Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
Topics: Adult; Biomarkers; Case-Control Studies; Fatty Liver; Fatty Liver, Alcoholic; Fluorodeoxyglucose F18; gamma-Glutamyltransferase; Humans; Linear Models; Liver; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Positron-Emission Tomography; Radiopharmaceuticals; Triglycerides; Ultrasonography | 2014 |
Intense FDG activity in focal hepatic steatosis.
Topics: Adult; Biopsy; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography | 2014 |
The combined effects of serum lipids, BMI, and fatty liver on 18F-FDG uptake in the liver in a large population from China: an 18F-FDG-PET/CT study.
Topics: Adult; Aged; Body Mass Index; China; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Lipids; Liver; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2015 |
Heterogeneity of intrahepatic fat distribution determined by (18)F-FDG PET and CT.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood Glucose; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Obesity; Positron Emission Tomography Computed Tomography; Retrospective Studies; Young Adult | 2016 |
Relationships of body habitus and SUV indices with signal-to-noise ratio of hepatic (18)F-FDG PET.
Topics: Adult; Aged; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity; Overweight; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Signal-To-Noise Ratio | 2016 |
Inverse association between liver fat content and hepatic glucose uptake in patients with type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Fatty Liver; Female; Fluorodeoxyglucose F18; Glucose; Humans; Hypoglycemic Agents; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones | 2008 |
Focal fat mimicking multiple hepatic metastases on FDG PET/CT imaging.
Topics: Breast Neoplasms; Carcinoma, Ductal; Diagnosis, Differential; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed | 2009 |
Quantitative assessment of the hepatic metabolic volume product in patients with diffuse hepatic steatosis and normal controls through use of FDG-PET and MR imaging: a novel concept.
Topics: Adult; Aged; Case-Control Studies; Diffusion; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography | 2010 |
Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values.
Topics: Adult; Aged; Aged, 80 and over; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Spiral Computed; Whole Body Imaging | 2010 |
Histamine regulation in glucose and lipid metabolism via histamine receptors: model for nonalcoholic steatohepatitis in mice.
Topics: Adiponectin; Adipose Tissue; Animals; Body Weight; Dietary Fats; Fatty Acid Synthases; Fatty Liver; Fluorodeoxyglucose F18; Glucose; Histamine; Hyperlipidemias; Leptin; Lipid Metabolism; Liver; Mice; Mice, Knockout; Radiopharmaceuticals; Receptors, Histamine H1; Receptors, Histamine H2; Sterol Regulatory Element Binding Proteins | 2010 |
Liver fat content in type 2 diabetes: relationship with hepatic perfusion and substrate metabolism.
Topics: Age of Onset; Blood Volume; Body Mass Index; Body Surface Area; Diabetes Mellitus, Type 2; Dietary Fats; Fatty Acids; Fatty Liver; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Kinetics; Liver; Magnetic Resonance Imaging; Male; Middle Aged; Perfusion; Portal Vein; Positron-Emission Tomography; Reference Values; Triglycerides | 2010 |
Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET/CT.
Topics: Case-Control Studies; Fatty Liver; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans.
Topics: Adipose Tissue, Brown; Adult; Blood Glucose; Body Mass Index; Fatty Liver; Fluorodeoxyglucose F18; Humans; Liver; Middle Aged; Multimodal Imaging; Non-alcoholic Fatty Liver Disease; Odds Ratio; Positron-Emission Tomography; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2011 |
TIMP3 overexpression in macrophages protects from insulin resistance, adipose inflammation, and nonalcoholic fatty liver disease in mice.
Topics: Adipose Tissue; Adiposity; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Diet, High-Fat; Fatty Liver; Fluorodeoxyglucose F18; Inflammation; Insulin Resistance; Macrophages; Mice; Non-alcoholic Fatty Liver Disease; Obesity; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-3 | 2012 |
[A case of focal fatty liver occurring after gastrectomy with difficulty in distinction from metastatic liver cancer ].
Topics: Aged; Diagnosis, Differential; Fatty Liver; Fluorodeoxyglucose F18; Gastrectomy; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Postoperative Complications; Stomach Neoplasms; Ultrasonography | 2005 |